Correlation Between Incyte and AngioDynamics

Can any of the company-specific risk be diversified away by investing in both Incyte and AngioDynamics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and AngioDynamics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Incyte and AngioDynamics, you can compare the effects of market volatilities on Incyte and AngioDynamics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of AngioDynamics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and AngioDynamics.

Diversification Opportunities for Incyte and AngioDynamics

0.63

Correlation Coefficient

Incyte AngioDynamics

Poor diversification

The 3 months correlation between Incyte and AngioDynamics is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and AngioDynamics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AngioDynamics and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with AngioDynamics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AngioDynamics has no effect on the direction of Incyte i.e., Incyte and AngioDynamics go up and down completely randomly.

Pair Corralation between Incyte and AngioDynamics

Given the investment horizon of 90 days Incyte is expected to under-perform the AngioDynamics. But the stock apears to be less risky and, when comparing its historical volatility, Incyte is 1.84 times less risky than AngioDynamics. The stock trades about -0.3 of its potential returns per unit of risk. The AngioDynamics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,247  in AngioDynamics on December 27, 2022 and sell it today you would lose (42.00)  from holding AngioDynamics or give up 3.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Incyte  vs.  AngioDynamics

Incyte

Incyte Performance

0 of 100

Over the last 90 days Incyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

AngioDynamics

AngioDynamics Performance

0 of 100

Over the last 90 days AngioDynamics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

Pair Trading with Incyte and AngioDynamics

The main advantage of trading using opposite Incyte and AngioDynamics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, AngioDynamics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will offset losses from the drop in AngioDynamics' long position.

	Incyte vs. Codexis
	Incyte vs. Calyxt Inc
	Incyte vs. Cumberland Pharmaceuticals
	Incyte vs. AcelRx Pharmaceuticals

The idea behind Incyte and AngioDynamics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

	AngioDynamics vs. Adapthealth Corp
	AngioDynamics vs. Aesthetic Medical Intl
	AngioDynamics vs. Addus HomeCare
	AngioDynamics vs. Adicet Bio

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Share Portfolio module to track or share privately all of your investments from the convenience of any device.